General Information of Disease (ID: DISMUZF4)

Disease Name Gilbert syndrome
Synonyms
hyperbilirubinemia, Arias type; hyperbilirubinemia, Gilbert type; hyperbilirubinemia 1; Gilbert-Meulengracht syndrome; Gilbert syndrome; familial cholemia; hyperbilirubinemia type 1; Gilbert's disease; Gilbert's syndrome; Gilbert disease; constitutional hyperbilirubinemia; hereditary nonhemolytic jaundice
Definition An autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice.
Disease Hierarchy
DIS6SVEE: Syndromic disease
DIS788JD: Hereditary hyperbilirubinemia
DISMUZF4: Gilbert syndrome
Disease Identifiers
MONDO ID
MONDO_0007745
MESH ID
D005878
UMLS CUI
C0017551
OMIM ID
143500
MedGen ID
4891
Orphanet ID
357
SNOMED CT ID
27503000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
UGT1A1 OTH1C8OJ Strong Autosomal recessive [1]
CNDP2 OTJR9436 Strong Genetic Variation [8]
CYP2D7 OTYJTL3S Strong Biomarker [9]
IBSP OT29944Y Strong Biomarker [10]
NT5C3A OT67KZJA Strong Genetic Variation [11]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCG5 TTKZ7WY Strong Genetic Variation [2]
G6PD TTKN8W0 Strong Biomarker [3]
SLC10A2 TTPI1M5 Strong Genetic Variation [2]
UGT1A1 TT34ZAF Strong Genetic Variation [4]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC35A2 DT0567K Limited Genetic Variation [5]
------------------------------------------------------------------------------------
This Disease Is Related to 9 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
UGT1A3 DEF2WXN moderate Genetic Variation [6]
UGT1A1 DEYGVN4 Strong Autosomal recessive [1]
UGT1A10 DEL5N6Y Strong Altered Expression [7]
UGT1A4 DELOY3P Strong Altered Expression [7]
UGT1A5 DEPF954 Strong Genetic Variation [6]
UGT1A6 DESD26P Strong Altered Expression [7]
UGT1A7 DEZO4N3 Strong Altered Expression [7]
UGT1A8 DE2GB8N Strong Altered Expression [7]
UGT1A9 DE85D2P Strong Genetic Variation [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DME(s)

References

1 UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia. J Pediatr. 2013 Jun;162(6):1146-52, 1152.e1-2. doi: 10.1016/j.jpeds.2012.11.042. Epub 2013 Jan 4.
2 Genetics of biliary lithiasis from an ethnic perspective.Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):119-25. doi: 10.1016/j.clinre.2012.09.002. Epub 2013 Jan 20.
3 Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases.Clin Chim Acta. 2016 Jul 1;458:51-4. doi: 10.1016/j.cca.2016.04.020. Epub 2016 Apr 20.
4 Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.Br J Haematol. 2020 Mar;188(5):784-795. doi: 10.1111/bjh.16244. Epub 2019 Oct 10.
5 Genetic susceptibility to Gilbert's syndrome in a valencian population; efficacy of the fasting test.Rev Clin Esp (Barc). 2017 Jan-Feb;217(1):1-6. doi: 10.1016/j.rce.2016.10.001. Epub 2016 Nov 17.
6 Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5024-9. doi: 10.1073/pnas.0913290107. Epub 2010 Mar 1.
7 Effect of UDP-glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome.Kaohsiung J Med Sci. 2019 Jul;35(7):432-439. doi: 10.1002/kjm2.12077. Epub 2019 Apr 24.
8 Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.Biochim Biophys Acta. 1998 Apr 28;1406(3):267-73. doi: 10.1016/s0925-4439(98)00013-1.
9 Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndrome.Ther Drug Monit. 2000 Jun;22(3):366-8. doi: 10.1097/00007691-200006000-00020.
10 Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1.Hepatology. 2001 Mar;33(3):627-32. doi: 10.1053/jhep.2001.22499.
11 Pyrimidine-5'-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5'-nucleotidase type I deficiency and influence of Gilbert's Syndrome on clinical expression.Blood Cells Mol Dis. 2014 Dec;53(4):246-52. doi: 10.1016/j.bcmd.2014.05.009. Epub 2014 Aug 18.